Compare IOTA (MIOTA) vs Enzyme (MLN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IOTA vs Enzyme — how do they compare? IOTA trades at Rp580.78 (market cap Rp2,66T, Rp102,72M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: IOTA is far larger — about 19831.5× Enzyme's market cap, and IOTA's circulating supply is 4,6B MIOTA versus 3,3M MLN for Enzyme. Which is the better fit depends on your goals — on Pluang, investors hold IOTA for 49 Days and Enzyme for 29 Days on average.
| MIOTA | MLN | |
|---|---|---|
Market Cap | Rp2,66T | Rp134,13M |
Volume (24h) | Rp102,72M | Rp104,56M |
Circulating Supply | 4,6B MIOTA | 3,3M MLN |
Typical Hold Time | 49 Days | 29 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IOTA is trading at Rp599.3 with a market cap of Rp2.75T, showing bearish technical signals overall with moving averages indicating selling pressure while oscillators remain neutral. The price is currently testing support at Rp596 with resistance at Rp617. No major protocol updates or ecosystem developments were reported recently.
Overall outlook remains cautious with technical weakness dominating. Key opportunities include potential bounce from support levels, while risks include continued bearish momentum and lack of recent fundamental catalysts. Investors should monitor volume patterns and network activity for directional cues.
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.
Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.
About IOTA
IOTA is a distributed ledger with one big difference: it isn’t actually a blockchain. Instead, its proprietary technology is known as Tangle, a system of nodes that confirm transactions. The foundation behind this platform says this offers far greater speeds than conventional blockchains — and an ideal footprint for the ever-expanding Internet of Things ecosystem.
Read more on MIOTA →About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →
